MYC and cancer: MYC knockout experiments in the animal models demonstrated that partial inactivation of the oncogene offers acute or sustained tumor regression promoting proliferation arrest, apoptosis, differentiation, and senescence in cancer cells (14,20,21).Therefore, the design of c-MYC-targeted therapeutics to restore its basal level of cellular expression holds a promising avenue in anti-cancer treatment (22).